Literature DB >> 16174962

Improved outcome in thoracoabdominal aortic aneurysm repair: the role of cerebrospinal fluid drainage.

Tatjana M Fleck1, Herbert Koinig, Reinhard Moidl, Martin Czerny, Carole Hamilton, Arno Schifferer, Marian Jelen, Ernst Wolner, Martin Grabenwoger.   

Abstract

INTRODUCTION: To evaluate the protective effect and the optimum duration of cerebrospinal fluid drainage (CSFD) during and after thoracoabdominal aortic aneurysm (TAAA) repair.
METHODS: From April 2001 to October 2003, we retrospectively compared 17 (n = 17) consecutive patients who have been electively operated on by Martin Grabenwoger for left heart bypass and selective perfusion of the visceral and renal organs.
RESULTS: The first 7 patients had CSFD for 72 hours; the duration of CSFD was increased to 100 hours in the remaining 10 patients. Median drained cerebrospinal fluid (CSF) volume was 680 milliliters in the 72-hour group versus 1441 milliliters in the 100-hour group. A characteristic increase in CSF volume was noted between POD No. 2 and POD No. 4 indicating persistent spinal cord edema. Univariate and multivariate analysis demonstrated that CSFD for 100 hours is a significant predictor for decreased incidence of late onset paraplegia (p < 0.001). The overall incidence of postoperative neurological deficit was 17.6% (3 of 17). There was one patient (6%) who developed permanent paraplegia and two patients (12%) with transient paraplegia. These patients sustained late-onset paraplegia 72 hours after surgery for removal of a CSFD device. Complete motor function could be restored after re-insertion of a CSFD device. In one patient, permanent paraplegia was evident after awakening from anesthesia. Because of technical difficulties, only two intercostal arteries could be re-implanted, which was obviously not sufficient to restore spinal cord perfusion. In contrast, no neurological deficit occurred in patients in whom a CSFD instrument was left for 100 hours.
CONCLUSION: The extended duration of CSFD may lower the risk of late-onset paraplegia and could improve outcome in patients undergoing thoracoabdominal aortic surgery.

Entities:  

Mesh:

Year:  2005        PMID: 16174962     DOI: 10.1385/NCC:2:1:011

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  26 in total

1.  A new predictive model for adverse outcomes after elective thoracoabdominal aortic aneurysm repair.

Authors:  S A LeMaire; C C Miller; L D Conklin; Z C Schmittling; C Köksoy; J S Coselli
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

2.  Spinal cord protection in descending thoracic and thoracoabdominal aortic repair.

Authors:  H J Safi; C C Miller
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

3.  Morbidity and mortality after extent II thoracoabdominal aortic aneurysm repair.

Authors:  Joseph S Coselli; Scott A LeMaire; Lon D Conklin; Cüneyt Köksoy; Zachary C Schmittling
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

4.  Functional outcome after thoracoabdominal aortic aneurysm repair.

Authors:  John E Rectenwald; Thomas S Huber; Tomas D Martin; C Keith Ozaki; Meenakshi Devidas; M Burress Welborn; James M Seeger
Journal:  J Vasc Surg       Date:  2002-04       Impact factor: 4.268

5.  Determinants of hospital length of stay after thoracoabdominal aortic aneurysm repair.

Authors:  T T t Huynh; C C Miller; A L Estrera; R Sheinbaum; S J Allen; H J Safi
Journal:  J Vasc Surg       Date:  2002-04       Impact factor: 4.268

6.  Neurologic outcome after thoracic and thoracoabdominal aortic aneurysm repair.

Authors:  A L Estrera; C C Miller; T T Huynh; E Porat; H J Safi
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

7.  Interventions for reversing delayed-onset postoperative paraplegia after thoracic aortic reconstruction.

Authors:  Albert T Cheung; Stuart J Weiss; Michael L McGarvey; Mark M Stecker; Michael S Hogan; Alison Escherich; Joseph E Bavaria
Journal:  Ann Thorac Surg       Date:  2002-08       Impact factor: 4.330

8.  Neurologic deficit in patients at high risk with thoracoabdominal aortic aneurysms: the role of cerebral spinal fluid drainage and distal aortic perfusion.

Authors:  H J Safi; S Bartoli; K R Hess; S S Shenaq; J R Viets; G R Butt; R Sheinbaum; H K Doerr; R Maulsby; V M Rivera
Journal:  J Vasc Surg       Date:  1994-09       Impact factor: 4.268

9.  A prospective randomized study of cerebrospinal fluid drainage to prevent paraplegia after high-risk surgery on the thoracoabdominal aorta.

Authors:  E S Crawford; L G Svensson; K R Hess; S S Shenaq; J S Coselli; H J Safi; P K Mohindra; V Rivera
Journal:  J Vasc Surg       Date:  1991-01       Impact factor: 4.268

10.  Cerebrospinal fluid drainage and distal aortic perfusion: reducing neurologic complications in repair of thoracoabdominal aortic aneurysm types I and II.

Authors:  H J Safi; K R Hess; M Randel; D C Iliopoulos; J C Baldwin; R K Mootha; S S Shenaq; R Sheinbaum; T Greene
Journal:  J Vasc Surg       Date:  1996-02       Impact factor: 4.268

View more
  4 in total

1.  [The vascular surgeon's role in intensive care].

Authors:  H Schelzig; K H Orend; L Sunder-Plassmann
Journal:  Chirurg       Date:  2006-08       Impact factor: 0.955

2.  Reproducible Motor Deficit Following Aortic Occlusion in a Rat Model Of Spinal Cord Ischemia.

Authors:  Jin-Young Hwang; Hye-Min Sohn; Jin-Hee Kim; Seongjoo Park; Jin-Woo Park; Mi-Sun Lim; Sung-Hee Han
Journal:  J Vis Exp       Date:  2017-07-22       Impact factor: 1.355

3.  The treatment of spinal cord ischemia following thoracic endovascular aortic repair.

Authors:  Michael L McGarvey; Michael T Mullen; Edward Y Woo; Joseph E Bavaria; Yanni G Augoustides; Steven R Messé; Albert T Cheung
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 4.  [Anesthesiologic procedure for elective aortic surgery].

Authors:  J Knapp; M Bernhard; H Rauch; A Hyhlik-Dürr; D Böckler; A Walther
Journal:  Anaesthesist       Date:  2009-11       Impact factor: 1.041

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.